Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pre-emptive Analgesics in Orthodontic Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03523988
Recruitment Status : Completed
First Posted : May 14, 2018
Results First Posted : October 30, 2018
Last Update Posted : October 30, 2018
Sponsor:
Information provided by (Responsible Party):
Andrew Keith, University of Washington

Brief Summary:
This study is designed to determine if the preemptive use of a combination of acetaminophen and ibuprofen is more effective in reducing pain following orthodontic tooth movement when compared to the use of acetaminophen and ibuprofen alone. Before their orthodontic appointment, participants will be administered acetaminophen (650mg), ibuprofen (400mg), or acetaminophen (650mg) + ibuprofen (400mg). Participants will be asked to record their pain intensity using a numerical (0-10) visual analog scale (VAS) during rest, light biting, and while chewing paraffin wax during the following time intervals: immediately following drug administration, 6 hours after, the morning after, and the second morning after orthodontic treatment.

Condition or disease Intervention/treatment Phase
NSAID Pain Management Drug: Acetaminophen Drug: Ibuprofen Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 73 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Patients of the University of Washington Graduate Orthodontics Clinic
Masking: Triple (Participant, Care Provider, Investigator)
Masking Description: The medications were prepared by the Kelley-Ross Compounding Group (Seattle, WA) and were identical in appearance. The bottles were labeled as "A", "B", or "C" and the identity of the medications were not revealed until after the data analysis was completed.
Primary Purpose: Treatment
Official Title: Effects of Pre-emptive Use of Combined Ibuprofen and Acetaminophen on Pain Control in Orthodontic Treatment
Actual Study Start Date : May 2, 2017
Actual Primary Completion Date : June 23, 2017
Actual Study Completion Date : August 1, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Orthodontia

Arm Intervention/treatment
Active Comparator: Acetaminophen
Acetaminophen 650mg powder in gel capsule taken by mouth before entering appointment
Drug: Acetaminophen
Acetaminophen gel capsule
Other Names:
  • Tylenol
  • Paracetamol

Active Comparator: Ibuprofen
Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Drug: Ibuprofen
Ibuprofen gel capsule
Other Name: Advil

Experimental: Acetaminophen and Ibuprofen
Acetaminophen 650mg and Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Drug: Acetaminophen
Acetaminophen gel capsule
Other Names:
  • Tylenol
  • Paracetamol

Drug: Ibuprofen
Ibuprofen gel capsule
Other Name: Advil




Primary Outcome Measures :
  1. Visual Analog Scale (VAS) Pain Scores at 6 Hours After Treatment [ Time Frame: 6 hours after orthodontic treatment ]

    Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.

    The VAS consisted of a 10cm numerical scale from 0, representing "no pain," to 10, representing "worst possible, unbearable, excruciating pain."


  2. Visual Analog Scale (VAS) Pain Scores at 1 Day After Treatment [ Time Frame: 1 day after orthodontic treatment ]

    Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.

    The VAS consisted of a 10cm numerical scale from 0, representing "no pain," to 10, representing "worst possible, unbearable, excruciating pain."


  3. Visual Analog Scale (VAS) Pain Scores at 2 Days After Treatment [ Time Frame: 2 days after orthodontic treatment ]

    Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.

    The VAS consisted of a 10cm numerical scale from 0, representing "no pain," to 10, representing "worst possible, unbearable, excruciating pain."




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 59 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

-Orthodontic patient presenting for orthodontic treatment

Exclusion Criteria:

  • History of taking an analgesic in the past six hours
  • Hypersensitivity to ibuprofen or acetaminophen
  • Aspirin-sensitive asthma
  • Renal or liver impairment
  • History of GI bleeding or ulcers
  • Cardiovascular disease, recent myocardial infarction, heart failure, or coronary artery bypass graft surgery
  • Currently taking antibiotics or other medications for a chronic systemic disease
  • Bleeding disorder
  • Pregnant or nursing

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03523988


Locations
Layout table for location information
United States, Washington
University of Washington
Seattle, Washington, United States, 98195
Sponsors and Collaborators
University of Washington
Investigators
Layout table for investigator information
Study Director: Anne-Marie Bollen, DDS, MS, PhD University of Washington
  Study Documents (Full-Text)

Documents provided by Andrew Keith, University of Washington:
Study Protocol  [PDF] April 19, 2017
Statistical Analysis Plan  [PDF] May 1, 2018
Informed Consent Form  [PDF] April 26, 2017


Layout table for additonal information
Responsible Party: Andrew Keith, Principal Investigator, University of Washington
ClinicalTrials.gov Identifier: NCT03523988     History of Changes
Other Study ID Numbers: STUDY00001679
First Posted: May 14, 2018    Key Record Dates
Results First Posted: October 30, 2018
Last Update Posted: October 30, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No

Keywords provided by Andrew Keith, University of Washington:
Pre-emptive analgesics
Acetaminophen
Ibuprofen

Additional relevant MeSH terms:
Layout table for MeSH terms
Acetaminophen
Ibuprofen
Analgesics
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Antipyretics
Anti-Inflammatory Agents, Non-Steroidal
Anti-Inflammatory Agents
Antirheumatic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action